-May 12, 2008
A consumer advocacy group is petitioning for the FDA to remove a Johnson and Johnson birth control patch from the market.
The transdermal birth control patch reportedly increases the chance of dangerous blood clots in consumers.
A Different Form of Birth Control
The birth control patch, Ortho Evra, is marketed in the U.S. by Ortho-McNeil, a pharmaceutical company that’s a subsidiary of Johnson & Johnson.
When the patch is applied to the skin it releases synthetic estrogen and progestin hormones immediately into the body to prevent pregnancy.
The patch is supposedly applied for three weeks at a time, then skipped for a week, much like the pill form of birth control.
Warning Already Added by FDA
The Ortho-Evra patch became controversial after an investigation conducted by the AP revealed that women using the patch were suffering from higher rates of life-threatening blood clots than women using other forms of birth control.
The FDA reportedly already added a warning label on the patch in January, claiming that women who choose to use the patch have double the risk of developing blood clots.
According to reports, women using the patch can be exposed to 60 percent more estrogen than other birth control users.
(Source: eFluxMedia)
Have you or someone you know been harmed by the Ortho-Evra Patch? If so, please contact us today to speak with a trustworthy attorney who will enable you and your loved ones to receive the legal support and guidance you need and deserve.
